Case report of Acute Myeloblastic Leukemia with blast count less than 20% in bone marrow

  • سال انتشار: 1396
  • محل انتشار: نوزدهمین همایش سالانه و دومین همایش بین المللی آسیب شناسی و طب آزمایشگاه
  • کد COI اختصاصی: ACPLMED19_046
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 472
دانلود فایل این مقاله

نویسندگان

Pardis Nematollahi

Department of Pathology, Isfahan University of Medical Science, Isfahan,Iran

Behnaz Sabbaghi

Department of Pathology, Isfahan University of Medical Science, Isfahan,Iran

Mohamad Hossein Sanei

Department of Pathology, Isfahan University of Medical Science, Isfahan,Iran

چکیده

Introduction: Acute Myleloblastic Leukemia is a precursor hamatopoietic malignancy which is seen in any age group and is diagnozed initially as detection of 20% myeloblast in PB or BMA. Based on 2016 WHO classification of hematolymphoid malignancies, some AML with recurrent cytogenetic abnormalities is dropped in one subgroup of AML.The categories of AML with t(8,21), inv(16), t(16,16), or t(15,17) are considered as acute leukemia without regard to blast cell count. Discussion: Patient is a 14 year old boy presenting with fever and petechiae in upper and lower limbs 4-5 days ago , lab data reveals severe leukocytosis, anemia and moderate thrombocytopenia. Imaging data shows only mild splenomegaly. Bone marrow sampling shows severe left shifted myeloid hyperplasia and about 5-6 percent blast, in multicolor flowcytometry about 3 percent blast is isolated. Inspite of oncologist persistence on leukemia according to patient clinical and lab data, diagnosis cannot be confirmed due to low blast count, pathologist is waiting for cytogenetic tests results for AML associated cytogenetic abnormality, surprisingly translocation(8,21) is detected in marrow aspirate and so final diagnosis of Acute Myeloblastic Leukemia is done because the category of AML with above cytogenetic abnormality is considered as AML without regard to blast cell count. Conclusion:In cases suspicious for acute leukemia with low blast count, cytogenetic tests should be performed because the presence of some recurrent cytogenetic abnormalities inspite of blast cell count is considered as AML.

کلیدواژه ها

Acute Myeloblatic Leukemia, Recurrent cytogenetic abnormality, low blast count

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.